Journal of lower genital tract disease
Audio Summaries

HPV-associated Cancer Diagnoses and Mortality in People With HIV in South Carolina During the Antiretroviral Therapy Era

Sep 14, 2026

The authors aimed to investigate whether individuals with HIV (PWH) and HPV-associated cancers (HACs) in South Carolina are diagnosed at younger ages, at more advanced stages, and experience higher mortality rates compared to those without HIV. The study found that PWH were diagnosed with HACs at younger ages and more frequently with specific cancers, such as anal, penile, and vulvar cancers, but overall cancer-related mortality did not increase for men with HIV, while women with HIV showed lower survival rates for oropharyngeal cancer. The authors suggest that HPV immunization and improved screening practices could help address disparities in HACs among PWH.

Impact of Treatment of Symptomatic Vaginal Infections on Female Sexual Function: A Prospective Study

Sep 11, 2026

This study aimed to evaluate the impact of treating symptomatic vaginitis on female sexual function and to identify predictors of persistent sexual dysfunction. The results showed a significant improvement in sexual function after treatment, with a reduction in the prevalence of female sexual dysfunction from 80.4% to 27.2%. Factors such as daily pad use and smoking were found to be independently associated with ongoing sexual dysfunction, highlighting the importance of addressing sexual health in women with vaginitis.

Intralesional Corticosteroid Therapy for Refractory Hyperkeratotic Vulvar Lichen Sclerosus: A Case Series

Sep 9, 2026

The authors aimed to evaluate the clinical response and safety of intralesional corticosteroid therapy in adult patients with refractory hyperkeratotic vulvar lichen sclerosus after excluding neoplasia. In a case series of three women, all patients achieved complete clinical resolution within four months, with significant improvements in their Vulvar Quality of Life Index scores and no reported adverse events during follow-up. The study suggests that intralesional triamcinolone may be an effective treatment option for this condition, though limitations such as the small sample size and lack of a control group are noted.

Heterogeneity in Risk of Recurrent CIN2+ Among Women With Genotype-Specific HPV Detected After Excision: A Cohort Study

Sep 2, 2026

The authors aimed to evaluate the recurrence risk of cervical intraepithelial neoplasia grade 2 or worse (CIN2+) following conization, specifically in relation to post-treatment HPV genotype, timing of HPV detection, and cone margin status. They found that early detection of HPV16 was associated with the highest recurrence rates, while other high-risk HPV types and HPV-negative results showed significantly lower risks. The study highlights the importance of HPV genotyping in assessing recurrence risk, which may enhance risk-stratified screening approaches.

A Modified LEEP Technique Employing Foley Catheter Traction: Feasibility and Technical Considerations

Aug 28, 2026

This study aimed to evaluate the feasibility and technical considerations of a modified loop electrosurgical excision procedure (LEEP) that utilizes Foley catheter traction for improved cervical stabilization and specimen integrity. The findings suggest that this modified technique is feasible and leads to fewer instances of specimen fragmentation compared to the standard LEEP, although further prospective studies are needed to validate these results in clinical practice.

Rethinking Prevention of Recurrent Bacterial Vaginosis: A Comparative Effectiveness Network Meta-Analysis

Aug 18, 2026

The authors aimed to evaluate the effectiveness of various preventive strategies for recurrent bacterial vaginosis (BV) in nonpregnant women, including partner treatment, consolidation therapy, and long-term maintenance interventions. Their network meta-analysis found that partner treatment significantly reduced BV recurrence, while consolidation therapies like probiotics and acidifying agents also showed promise, particularly in different baseline risk groups. Overall, vaginal probiotics and acidifying agents emerged as the most supported nonantibiotic options for preventing BV recurrence.

Comparison of Colorimetric LAMP and PCR for High-risk HPV Detection: Implications for Cervical Cancer Screening

Aug 7, 2026

The authors aimed to evaluate the diagnostic performance of a colorimetric loop-mediated isothermal amplification (LAMP) assay as a rapid alternative to conventional PCR for detecting high-risk HPV types associated with cervical cancer. Their findings demonstrated that the LAMP assay exhibited high sensitivity (97.8% for HPV types 16 and 18, and 100% for other types) and specificity (100%), suggesting it could serve as an effective point-of-care screening tool, especially in resource-limited settings.

Extended HPV Genotyping for Risk Stratification in Cervical Screening: A Population-based Study

Aug 7, 2026

The authors aimed to evaluate the effectiveness of extended HPV genotyping for risk stratification in cervical cancer screening by analyzing its association with cytology and histology outcomes in a large population-based cohort. Their findings revealed a significant gradient of oncogenic risk, with high-risk HPV genotypes correlating with increased rates of high-grade disease, thereby supporting the use of risk stratification in clinical management of cervical cancer screening programs.

Vulvar Crohn's-Case Series and Review of Treatment With Ustekinumab

Jul 28, 2026

The authors aim to explore the effectiveness of ustekinumab in treating cutaneous vulvar Crohn's disease (VCD), a rare and challenging condition. Through a case series of three patients, they demonstrate that ustekinumab can lead to remission in some cases, while also highlighting the importance of individualized treatment approaches based on disease characteristics and patient history. The findings suggest that interleukin inhibitors may be a valuable option for patients with refractory VCD, especially after failure of TNF-alpha inhibitors.

Investigating Discrepancies Between Original and Review Diagnoses in Cervical Cancer and Precancerous Lesions

Jul 24, 2026

The authors aimed to evaluate the prevalence and factors associated with discrepancies between original and review pathology diagnoses in cervical cancer and precancerous lesions. Their study found that 58.2% of cases had discrepancies, with 33.2% classified as major, which could significantly impact treatment decisions. The findings suggest that mandatory pathology reviews for cervical lesions are necessary to ensure accurate diagnoses and appropriate management.